Skip to Content
Merck
CN
  • Four types of fatty acids exert differential impact on pancreatic cancer growth.

Four types of fatty acids exert differential impact on pancreatic cancer growth.

Cancer letters (2015-02-14)
Ming Yu, Hongyi Liu, Yijie Duan, Dapeng Zhang, Shasha Li, Feng Wang
ABSTRACT

Increased fatty acids (FAs) regulate pancreatic cancer progression, however, the detailed mechanism is not clear, and different forms of FAs may play diversified roles in pancreatic cancer. To elucidate the underlying mechanism, we compared the effects of four major types of FAs on pancreatic cancer growth both in cell culture and in a mouse model. HPAF pancreatic cancer cells were implanted in nude mice for 14 weeks, and the mice were fed with four different high-fat/high-energy diets (15% fat, 4 kcal/g), an iso-caloric diet (5% fat, 4 kcal/g) and a normal diet (4% fat, 3 kcal/g). The high fat diets were rich in saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-6 and n-3 polyunsaturated fatty acids (n6- and n3PUFAs), respectively. While n3PUFA diet decreased tumor viability, the other high fat diets stimulated tumor viability by apparently different mechanisms. For instance, xenografts whose carriers were fed with SFA diet had marked expression of cancer-related proteins and lipid droplets. Although mice that were fed with MUFA- and n6PUFA diets had pancreatic tumors of similar size, liver metastasis occurred more frequently in those with the n6PUFA diet. In experiments in vitro, the HPAF-cell population was increased by SFAs and MUFAs, decreased by n3PUFAs and not changed by n6PUFAs. In conclusion, different fatty acids have different impact on pancreatic cancer cells. The effects of fatty acids on pancreatic cancer cells were consistent in vivo and in vitro except that n6PUFAs only had regulatory effects in vivo.

MATERIALS
Product Number
Brand
Product Description

Supelco
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Linoleic acid, technical, 58-74% (GC)
Sigma-Aldrich
Linolenic acid, ~70% (GC)
Sigma-Aldrich
Palmitic acid, ≥98%, FCC, FG
Sigma-Aldrich
Lauric acid, ≥98%, FCC, FG
Sigma-Aldrich
Lauric acid, natural, ≥98%, FCC, FG
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Sigma-Aldrich
Palmitoleic acid, ≥98.5% (GC), liquid
Sigma-Aldrich
Linolenic acid, ≥99%
Sigma-Aldrich
Palmitic acid, ≥99%
Sigma-Aldrich
Linoleic acid, liquid, BioReagent, suitable for cell culture
USP
Palmitic acid, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Palmitic acid, ≥98% palmitic acid basis (GC)
Supelco
Palmitic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Linolenic acid, analytical standard
Supelco
Palmitoleic acid, analytical standard
Supelco
Linoleic acid, analytical standard
Supelco
Palmitic acid, analytical standard
Lauric acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Palmitic acid, natural, 98%, FG
Palmitic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
Oleic acid, Selectophore, ≥99%
Sigma-Aldrich
(L)-Dehydroascorbic acid
Sigma-Aldrich
Arachidonic acid, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Oleic acid, natural, FCC
Sigma-Aldrich
Oleic acid, technical grade, 90%
Sigma-Aldrich
Oleic acid, meets analytical specification of Ph, Eur., 65.0-88.0% (GC)
Sigma-Aldrich
Dodecanoic acid, ≥99% (GC/titration)
Sigma-Aldrich
Oleic acid, ≥99% (GC)
Sigma-Aldrich
Oleic acid, suitable for cell culture, BioReagent